{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:03:05Z","timestamp":1788184985293,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473376"],"award-info":[{"award-number":["82473376"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province","award":["2021ZQNZD010"],"award-info":[{"award-number":["2021ZQNZD010"]}]},{"name":"Startup Fund for scientific research, Fujian Medical University","award":["2020QH1107"],"award-info":[{"award-number":["2020QH1107"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-40939-z","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:04:40Z","timestamp":1772784280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A nutritional risk index-based nomogram for predicting prognosis and identifying induction chemotherapy beneficiaries in nasopharyngeal carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Sunqin","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"issue":"11","key":"40939_CR1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","volume":"18","author":"KCW Wong","year":"2021","unstructured":"Wong, K. C. W. et al. Nasopharyngeal carcinoma: an evolving paradigm. Nat. Rev. Clin. Oncol. 18 (11), 679\u2013695 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10192","key":"40939_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen, Y. P. et al. Nasopharyngeal carcinoma. Lancet 394 (10192), 64\u201380 (2019).","journal-title":"Lancet"},{"issue":"6","key":"40939_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","volume":"16","author":"P Blanchard","year":"2015","unstructured":"Blanchard, P. et al. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol. 16 (6), 645\u2013655 (2015).","journal-title":"Lancet Oncol."},{"issue":"10","key":"40939_CR4","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/annonc\/mdz231","volume":"30","author":"MF Ji","year":"2019","unstructured":"Ji, M. F. et al. Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China. Ann. Oncol. 30 (10), 1630\u20131637 (2019).","journal-title":"Ann. Oncol."},{"key":"40939_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.oraloncology.2016.10.014","volume":"62","author":"H Peng","year":"2016","unstructured":"Peng, H. et al. Optimize the cycle of neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: A propensity score matching analysis. Oral Oncol. 62, 78\u201384 (2016).","journal-title":"Oral Oncol."},{"issue":"22","key":"40939_CR6","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1200\/JCO.22.00327","volume":"40","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial. J. Clin. oncology: official J. Am. Soc. Clin. Oncol. 40 (22), 2420\u20132425 (2022).","journal-title":"J. Clin. oncology: official J. Am. Soc. Clin. Oncol."},{"key":"40939_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejca.2019.07.007","volume":"119","author":"Q Yang","year":"2019","unstructured":"Yang, Q. et al. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial. Eur. J. Cancer. 119, 87\u201396 (2019).","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"40939_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ijc.32099","volume":"145","author":"WF Li","year":"2019","unstructured":"Li, W. F. et al. Concurrent chemoradiotherapy with\/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial. Int. J. Cancer. 145 (1), 295\u2013305 (2019).","journal-title":"Int. J. Cancer"},{"issue":"1","key":"40939_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ijrobp.2010.09.011","volume":"82","author":"SF Su","year":"2012","unstructured":"Su, S. F. et al. Long-Term Outcomes of Early-Stage Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy Alone. Int. J. Radiation Oncology*Biology*Physics. 82 (1), 327\u2013333 (2012).","journal-title":"Int. J. Radiation Oncology*Biology*Physics"},{"key":"40939_CR10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2147\/CMAR.S239729","volume":"12","author":"P Wu","year":"2020","unstructured":"Wu, P. et al. Management of Chemotherapy for Stage II Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era: A Review. Cancer Manage. Res. 12, 957\u2013963 (2020).","journal-title":"Cancer Manage. Res."},{"issue":"1","key":"40939_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12885-020-6555-7","volume":"20","author":"SL Liu","year":"2020","unstructured":"Liu, S. L. et al. Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level. BMC Cancer. 20 (1), 89 (2020).","journal-title":"BMC Cancer"},{"issue":"11","key":"40939_CR12","first-page":"638","volume":"31","author":"J Pingping","year":"2023","unstructured":"Pingping, J. et al. Nutritional status and its correlation to prognosis of nasopharyngeal carcinoma patients in different ages in China: a multicenter cohort study. Support. Care Cancer. 31 (11), 638 (2023).","journal-title":"Support. Care Cancer"},{"issue":"15","key":"40939_CR13","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1158\/0008-5472.CAN-18-0155","volume":"78","author":"C Lavalette","year":"2018","unstructured":"Lavalette, C. et al. Cancer-Specific and General Nutritional Scores and Cancer Risk: Results from the Prospective NutriNet-Sant\u00e9 Cohort. Cancer Res. 78 (15), 4427\u20134435 (2018).","journal-title":"Cancer Res."},{"issue":"1","key":"40939_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jgo.2020.06.020","volume":"12","author":"ME Hamaker","year":"2021","unstructured":"Hamaker, M. E. et al. Nutritional status and interventions for patients with cancer - A systematic review. J. Geriatric Oncol. 12 (1), 6\u201321 (2021).","journal-title":"J. Geriatric Oncol."},{"issue":"5","key":"40939_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1017\/S0007114518002222","volume":"122","author":"MJ Wiseman","year":"2018","unstructured":"Wiseman, M. J. Nutrition and cancer: prevention and survival. Br. J. Nutr. 122 (5), 481\u2013487 (2018).","journal-title":"Br. J. Nutr."},{"key":"40939_CR16","doi-asserted-by":"publisher","first-page":"110943","DOI":"10.1016\/j.nut.2020.110943","volume":"78","author":"Q Ou","year":"2020","unstructured":"Ou, Q. et al. Grading and prognosis of weight loss before and after treatment with optimal cutoff values in nasopharyngeal carcinoma. Nutrition 78, 110943 (2020).","journal-title":"Nutrition"},{"issue":"5","key":"40939_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hed.23357","volume":"36","author":"G Li","year":"2014","unstructured":"Li, G. et al. Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: Long-term outcomes of 512 patients from a single institution. Head Neck. 36 (5), 660\u2013666 (2014).","journal-title":"Head Neck"},{"issue":"1","key":"40939_CR18","doi-asserted-by":"publisher","first-page":"10744","DOI":"10.1038\/s41598-020-67285-y","volume":"10","author":"M Sasaki","year":"2020","unstructured":"Sasaki, M. et al. The Geriatric Nutritional Risk Index predicts postoperative complications and prognosis in elderly patients with colorectal cancer after curative surgery. Sci. Rep. 10 (1), 10744 (2020).","journal-title":"Sci. Rep."},{"issue":"2","key":"40939_CR19","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/odi.14035","volume":"29","author":"A Abe","year":"2021","unstructured":"Abe, A. et al. Correlation between geriatric nutritional risk index and oral condition in gastric cancer patients. Oral Dis. 29 (2), 836\u2013842 (2021).","journal-title":"Oral Dis."},{"issue":"7","key":"40939_CR20","doi-asserted-by":"publisher","first-page":"e0271073","DOI":"10.1371\/journal.pone.0271073","volume":"17","author":"N Miyoshi","year":"2022","unstructured":"Miyoshi, N. et al. Geriatric nutritional risk index as a prognostic factor in patients with recurrent pancreatic cancer. Plos One. 17 (7), e0271073 (2022).","journal-title":"Plos One"},{"issue":"9","key":"40939_CR21","first-page":"5371","volume":"29","author":"YY Duan","year":"2021","unstructured":"Duan, Y. Y. et al. Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective study. Support. Care Cancer. 29 (9), 5371\u20135381 (2021).","journal-title":"Support. Care Cancer"},{"issue":"3","key":"40939_CR22","first-page":"225","volume":"33","author":"J Song","year":"2025","unstructured":"Song, J. et al. Prognostic value of prognostic nutritional index in patients with nasopharyngeal carcinoma treated with endostar and concurrent chemoradiotherapy. Support. Care Cancer. 33 (3), 225 (2025).","journal-title":"Support. Care Cancer"},{"issue":"12","key":"40939_CR23","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1001\/jamaoncol.2024.4354","volume":"10","author":"JJ Pan","year":"2024","unstructured":"Pan, J. J. et al. Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification. JAMA Oncol. 10 (12), 1627\u20131635 (2024).","journal-title":"JAMA Oncol."},{"issue":"3","key":"40939_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ccell.2023.12.020","volume":"42","author":"XJ Du","year":"2024","unstructured":"Du, X. J. et al. Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma. Cancer Cell. 42 (3), 464\u2013473e463 (2024).","journal-title":"Cancer Cell."},{"issue":"7","key":"40939_CR25","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/ijc.31856","volume":"144","author":"VHF Lee","year":"2018","unstructured":"Lee, V. H. F. et al. The addition of pretreatment plasma Epstein\u2013Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification. Int. J. Cancer. 144 (7), 1713\u20131722 (2018).","journal-title":"Int. J. Cancer"},{"issue":"6","key":"40939_CR26","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1007\/s12094-024-03781-1","volume":"27","author":"GY Cheng","year":"2024","unstructured":"Cheng, G. Y. et al. A prognostic nomogram for patients with III\u2013IV nasopharyngeal carcinoma based on dynamic changes in the inflammatory and nutrition index. Clin. Transl. Oncol. 27 (6), 2638\u20132650 (2024).","journal-title":"Clin. Transl. Oncol."},{"key":"40939_CR27","doi-asserted-by":"publisher","first-page":"109445","DOI":"10.1016\/j.radonc.2022.109445","volume":"179","author":"JR Mao","year":"2023","unstructured":"Mao, J. R. et al. Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission? Radiother. Oncol. 179, 109445 (2023).","journal-title":"Radiother. Oncol."},{"issue":"10","key":"40939_CR28","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.1007\/s00330-024-10678-8","volume":"34","author":"SX Wang","year":"2024","unstructured":"Wang, S. X. et al. Radiomics-based nomogram guides adaptive de-intensification in locoregionally advanced nasopharyngeal carcinoma following induction chemotherapy. Eur. Radiol. 34 (10), 6831\u20136842 (2024).","journal-title":"Eur. Radiol."},{"issue":"24","key":"40939_CR29","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1056\/NEJMoa032260","volume":"350","author":"JC Lin","year":"2004","unstructured":"Lin, J. C. et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl. J. Med. 350 (24), 2461\u20132470 (2004).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"40939_CR30","doi-asserted-by":"publisher","first-page":"20229","DOI":"10.1038\/s41598-024-71360-z","volume":"14","author":"WN Fang","year":"2024","unstructured":"Fang, W. N. et al. A scoring system based on inflammatory and nutritional indicators to predict the long-term survival of patients with non-metastatic nasopharyngeal carcinoma. Sci. Rep. 14 (1), 20229 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"40939_CR31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12885-025-13565-7","volume":"25","author":"YC Huang","year":"2025","unstructured":"Huang, Y. C., Chen, S. W. & Chiang, Y. S. Prognostic role of geriatric nutritional risk index (GNRI) and controlling nutritional status (CONUT) on outcomes in patients with head and neck cancer: a systematic review and meta-analysis. BMC Cancer. 25 (1), 242 (2025).","journal-title":"BMC Cancer"},{"issue":"3","key":"40939_CR32","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1007\/s00464-020-07487-7","volume":"35","author":"N Hirahara","year":"2020","unstructured":"Hirahara, N. et al. Prediction of postoperative complications and survival after laparoscopic gastrectomy using preoperative Geriatric Nutritional Risk Index in elderly gastric cancer patients. Surg. Endosc. 35 (3), 1202\u20131209 (2020).","journal-title":"Surg. Endosc."},{"issue":"7","key":"40939_CR33","doi-asserted-by":"publisher","first-page":"532","DOI":"10.21037\/atm-20-6493","volume":"9","author":"QN Tang","year":"2021","unstructured":"Tang, Q. N. et al. Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort study. Annals Translational Med. 9 (7), 532\u2013532 (2021).","journal-title":"Annals Translational Med."},{"issue":"2","key":"40939_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10388-018-0644-6","volume":"16","author":"N Kubo","year":"2018","unstructured":"Kubo, N. et al. The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer. Esophagus 16 (2), 147\u2013154 (2018).","journal-title":"Esophagus"},{"issue":"3","key":"40939_CR35","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.clnu.2018.05.010","volume":"38","author":"NB de Pinho","year":"2019","unstructured":"de Pinho, N. B. et al. Malnutrition associated with nutrition impact symptoms and localization of the disease: Results of a multicentric research on oncological nutrition. Clin. Nutr. 38 (3), 1274\u20131279 (2019).","journal-title":"Clin. Nutr."},{"issue":"8","key":"40939_CR36","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1002\/hed.27689","volume":"46","author":"YN Jin","year":"2024","unstructured":"Jin, Y. N. et al. Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in elderly patients with stage III-IVa nasopharyngeal carcinoma: A real\u2010world study based on medical comorbidities. Head Neck. 46 (8), 2020\u20132030 (2024).","journal-title":"Head Neck"},{"issue":"7","key":"40939_CR37","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/curroncol32070372","volume":"32","author":"X Lin","year":"2025","unstructured":"Lin, X. et al. Insights into the Prognostic Efficacy of the Geriatric Nutritional Risk Index for Nasopharyngeal Carcinoma in the Era of Volumetric Modulated Arc Therapy: A Nomogram for Predicting Long-Term Survival Outcomes. Curr. Oncol. 32 (7), 372 (2025).","journal-title":"Curr. Oncol."},{"key":"40939_CR38","doi-asserted-by":"publisher","first-page":"e081557","DOI":"10.1136\/bmj-2024-081557","volume":"389","author":"WH Xie","year":"2025","unstructured":"Xie, W. H. et al. Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial. Bmj 389, e081557 (2025).","journal-title":"Bmj"},{"issue":"6","key":"40939_CR39","doi-asserted-by":"publisher","first-page":"6994","DOI":"10.1002\/cam4.5497","volume":"12","author":"WL Qu","year":"2022","unstructured":"Qu, W. L. et al. Chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Who really needs it. Cancer Med. 12 (6), 6994\u20137004 (2022).","journal-title":"Cancer Med."},{"key":"40939_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejca.2016.12.009","volume":"73","author":"H Liang","year":"2017","unstructured":"Liang, H. et al. Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area. Eur. J. Cancer. 73, 48\u201360 (2017).","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"40939_CR41","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/hed.27011","volume":"44","author":"YT Jiang","year":"2022","unstructured":"Jiang, Y. T. et al. Prognostic significance of wait time for radical radiotherapy in locoregionally advanced nasopharyngeal carcinoma. Head Neck. 44 (5), 1182\u20131191 (2022).","journal-title":"Head Neck"},{"issue":"9","key":"40939_CR42","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.7150\/jca.56397","volume":"12","author":"W Li","year":"2021","unstructured":"Li, W. et al. Integrating pre- and post-treatment Plasma Epstein-Barr Virus DNA levels for better prognostic prediction of Nasopharyngeal Carcinoma. J. Cancer. 12 (9), 2715\u20132722 (2021).","journal-title":"J. Cancer"},{"key":"40939_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejca.2021.05.022","volume":"153","author":"AWM Lee","year":"2021","unstructured":"Lee, A. W. M. et al. A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma. Eur. J. Cancer. 153, 109\u2013122 (2021).","journal-title":"Eur. J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40939-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40939-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40939-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:02:38Z","timestamp":1773392558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40939-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40939"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40939-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics committees of The Second Affiliated Hospital of Fujian Medical University (Approval No. 2025\u2009\u2212\u2009544) and Fujian Cancer Hospital (Approval No. K2025-321-01). Given the observational and retrospective nature, the requirement for written informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"8848"}}